Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 1

Conditions

Lymphoma 112Lymphoma, Large B-Cell, Diffuse 77Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Leukemia 47Burkitt Lymphoma 45Lymphoma, Non-Hodgkin 35Lymphoma, Mantle-Cell 28Lymphoma, Follicular 27Hodgkin Disease 22Neuroblastoma 19Central Nervous System Neoplasms 19Sarcoma 18Lymphoma, B-Cell 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Large-Cell, Immunoblastic 12Lymphoma, T-Cell, Peripheral 11Lymphoma, Large-Cell, Anaplastic 11Neoplasms 10Multiple Myeloma 10Dendritic Cell Sarcoma, Interdigitating 10Sarcoma, Ewing 9Rhabdomyosarcoma 9Retinoblastoma 9Medulloblastoma 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Biphenotypic, Acute 8Recurrence 7Neuroectodermal Tumors, Primitive, Peripheral 7Lymphoma, T-Cell 7HIV Infections 7

Interventions

Imatinib Mesylate 60Cyclophosphamide 57fludarabine phosphate 51fludarabine 43Whole-Body Irradiation 41Mycophenolic Acid 41Tacrolimus 33nilotinib 31Dasatinib 31Busulfan 29Peripheral Blood Stem Cell Transplantation 23Cyclosporine 22Melphalan 21Thiotepa 20Granulocyte Colony-Stimulating Factor 19Filgrastim 18thymoglobulin 17Cytarabine 17Antilymphocyte Serum 15Stem Cell Transplantation 14sargramostim 13Methotrexate 13ponatinib 12asciminib 10Cyclosporins 10Cord Blood Stem Cell Transplantation 10bosutinib 9Rituximab 9Interferon-alpha 9Clofarabine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Vincristine × Clear all
NCT01670084 2015-10-30

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Mayo Clinic

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00763763 2011-10-05

AFR07

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed
55 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡